Abstract:Topic: 20. Lymphoma Biology & Translational Research Background: T-cell large granular lymphocytic leukemia (T-LGLL) is a chronic lymphoproliferative disease of mature T cells, characterized by monoclonal T-cell large granular lymphocytosis, often clinically manifest as bone marrow failure and accompany with autoimmune symptoms. Immunosuppressive therapies are effective, but the dominant clone may persist even in responders. The pathogenesis of T-LGLL has not been fully elucidated. In this study, single-cell RNA sequencing and V(D)J profiling were performed to discern clonotypes and gene expression patterns of T lymphocytes from T-LGLL patients. Aims: To identify the biomarkers of leukemic large granular lymphocytes (LGLs) and explore novel agent for treating T-LGLL. Methods: Peripheral blood samples were collected from five T-LGLL patients, three T-cell clones of uncertain significance (T-CUS) patients and three healthy donors. single-cell RNA library was performed on the 10x Genomics Chromium Single Cell V(D)J and 5’ Gene Expression platform, and sequencing obtained on the Illumina Platform. Barcode assignment, alignment, unique molecular index counting and T cell receptor sequence assembly were performed using Cell Ranger 6.1.0. Immune cells were clustered and annotated, then transcriptome characteristics of each group of cells were analyzed, T cell receptor (TCR) clonetype and clonesize were identified. Results: By analyzing the characteristics of transcriptome and immune library of CD8 T cells from all samples, terminal effector T cells were divided into three clusters (which named CD8 TE1, CD8 TE2 and CD8 TE3). Almost all of TE3 cluster, which characterized by decreased clonetype diversity, were from T-LGLL patients. To identify whether TE3 cluster was pathogenic, we mapped the transcriptome on previous sequencing of T-LGLLs (Nat commun(2022)13:1981 and Nat commun (2022)13:1982) and verified TE3 cluster was the leukemic subpopulation. Compared with non-leukemic effector T cells, this leukemic subpopulation demonstrated higher toxicity and increased proliferative function. Interestingly, upregulated exhausted genes were also observed in this cluster. Furthermore, cell killing, TCR activation, interferon γ signaling pathway and cytokine production were upregulated in leukemic cluster. Remarkablely, the leukemic effector T cells demonstrated a lower level of killer cell lectinlike receptor G1 (KLRG1). We also verified the significantly decreased expression of surface KLRG1 on CD3+CD8+CD57+ cells in other five T-LGLL patients. Moreover, up-regulated PI3K-AKT pathway was observed in this KLRG1- leukemic subpopulation. Proliferation and cytotoxicity of leukemic lymphocytes from patients were significantly decreased by PI3K inhibitor. Summary/Conclusion: Large granular lymphocytes is a typical KLRG1- clonal T effector cluster, characterized by increased cytotoxicity and exhaustion. PI3K inhibitor, which could restrain proliferation and effector function of leukemic lymphocytes, is a promising agent for T-LGLL. Keywords: LGL

PEG10 amplification at 7q21.3 potentiates large-cell transformation in cutaneous T-cell lymphoma

Abrogation of USP9X is a potential strategy to decrease PEG10 levels and impede tumor progression in cutaneous T-cell lymphoma

PEG10 Directly Regulated by E2Fs Might Have a Role in the Development of Hepatocellular Carcinoma.

HIF1A-dependent Overexpression of MTFP1 Promotes Lung Squamous Cell Carcinoma Development by Activating the Glycolysis Pathway

Comprehensive Profiling of MDM2/TP53 Genomic Aberration in Chinese Patients with Diverse Malignancies.

Molecular Biomarker Exploration of Rituximab plus CHOP Therapy in Real-World Diffuse Large B-Cell Lymphoma Patients

Genomic profiling of Mycosis Fungoides identifies patients at high risk of disease progression

Clinicopathologic features and outcomes of acute leukemia harboring PICALM::MLLT10 fusion

Elevated ITGA5 facilitates hyperactivated mTORC1-mediated progression of laryngeal squamous cell carcinoma via upregulation of EFNB2

P1242: A TRUELY LEUKEMIC SUBPOPULATION IDENTIFIED BY SINGLE CELL SEQUENCING IN T LARGE GRANULAR LYMPHOCYTIC LEUKEMIA

Genomic and global gene expression profiling in pediatric and young adult acute leukemia with PICALM::MLLT10 Fusion

Single-cell transcriptomics links malignant T cells to the tumor immune landscape in cutaneous T cell lymphoma

Pten-NOLC1 Fusion Promotes Cancers Involving MET and EGFR Signalings

ATF5 promotes malignant T cell survival through the PI3K/AKT/mTOR pathway in cutaneous T cell lymphoma

Abstract 2907: Therapeutic targeting miR-146a and miR-21 induce malignant cell death and regulate CD8+ T-cell function in mycosis fungoides with large-cell transformation

Whole-genome sequencing reveals potent therapeutic strategy for monomorphic epitheliotropic intestinal T-cell lymphoma

Single-cell RNA sequencing unveils the communications between malignant T and myeloid cells contributing to tumor growth and immunosuppression in cutaneous T-cell lymphoma

TP63 fusions drive multicomplex enhancer rewiring, lymphomagenesis, and EZH2 dependence

The genetic landscape of histologically transformed marginal zone lymphomas

Abnormal Cellular Populations Shape Thymic Epithelial Tumor Heterogeneity and Anti-Tumor by Blocking Metabolic Interactions in Organoids

Personalized Medicine Modality Based on Patient-Derived Xenografts from a Malignant Transformed GCTB Harboring H3F3A G34W Mutation